KeyCorp Comments on Agilent Technologies, Inc.'s Q3 2022 Earnings (NYSE:A) – MarketBeat

Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:

Agilent Technologies, Inc. (NYSE:A – Get Rating) – KeyCorp lowered their Q3 2022 earnings per share estimates for Agilent Technologies in a research note issued on Wednesday, June 1st. KeyCorp analyst P. Knight now expects that the medical research company will post earnings per share of $1.20 for the quarter, down from their prior estimate of $1.22. KeyCorp has a “Overweight” rating and a $155.00 price target on the stock. KeyCorp also issued estimates for Agilent Technologies’ Q4 2022 earnings at $1.35 EPS, FY2022 earnings at $4.90 EPS, FY2023 earnings at $5.42 EPS and FY2024 earnings at $6.16 EPS. Agilent Technologies (NYSE:A – Get Rating) last released its earnings results on Tuesday, May 24th. The medical research company reported $1.13 earnings per share for the quarter, beating analysts’ consensus estimates of $1.12 by $0.01. The business had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.62 billion. Agilent Technologies had a net margin of 19.35% and a return on equity of 27.42%. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same quarter last year, the firm earned $0.97 earnings per share.
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
A number of other analysts have also commented on the stock. StockNews.com lowered shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Friday, May 27th. Cowen dropped their price objective on shares of Agilent Technologies from $187.00 to $178.00 and set an “outperform” rating on the stock in a report on Wednesday, February 23rd. Citigroup dropped their price objective on shares of Agilent Technologies from $190.00 to $175.00 and set a “buy” rating on the stock in a report on Wednesday, February 23rd. Robert W. Baird increased their price target on shares of Agilent Technologies from $155.00 to $161.00 and gave the stock an “outperform” rating in a report on Wednesday, May 25th. Finally, Stifel Nicolaus lowered their target price on shares of Agilent Technologies from $169.00 to $145.00 and set a “hold” rating on the stock in a research note on Wednesday, February 23rd. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $160.58.
Shares of Agilent Technologies stock opened at $129.10 on Friday. Agilent Technologies has a 1 year low of $112.64 and a 1 year high of $179.57. The company has a current ratio of 2.01, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. The firm has a market capitalization of $38.56 billion, a PE ratio of 31.11, a price-to-earnings-growth ratio of 2.51 and a beta of 1.05. The firm’s 50 day moving average is $125.79 and its 200 day moving average is $138.00.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC bought a new stake in Agilent Technologies in the 4th quarter worth about $31,000. Glassman Wealth Services grew its stake in shares of Agilent Technologies by 47.4% during the 4th quarter. Glassman Wealth Services now owns 230 shares of the medical research company’s stock valued at $37,000 after purchasing an additional 74 shares during the period. Larson Financial Group LLC bought a new stake in shares of Agilent Technologies during the 4th quarter valued at about $39,000. Riverview Trust Co bought a new stake in shares of Agilent Technologies during the 1st quarter valued at about $33,000. Finally, CVA Family Office LLC bought a new stake in shares of Agilent Technologies during the 4th quarter valued at about $41,000.
In other news, SVP Michael Tang sold 1,210 shares of Agilent Technologies stock in a transaction dated Friday, March 18th. The stock was sold at an average price of $136.21, for a total value of $164,814.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 27th. Shareholders of record on Tuesday, July 5th will be given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Friday, July 1st. Agilent Technologies’s dividend payout ratio is currently 20.24%.
Agilent Technologies Company Profile (Get Rating)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
Further Reading

• Get a free copy of the StockNews.com research report on Agilent Technologies (A)
• Alibaba Group: Rallying on Fundamentals & Improved Macro Backdrop
• Investing in Chewy Will Require More Than One Earnings Report
• Hormel Foods Sends A Message To The Market 
• JFrog Stock is Ready to Leap
• PVH Corp. Looks Sharp For A Major Reversal 

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Agilent Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Agilent Technologies wasn’t on the list.
While Agilent Technologies currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The 5 Stocks Here
 
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
In this episode, Kate’s guest is Tyler Laundon, editor of the Cabot Small-Cap Confidential and grand slam advisory Cabot Early Opportunities newsletters. Tyler shares his analysis of the small-cap asset class, within the lens of the broader market. He also offers some stocks he’s eyeing right now as potential watch-list candidates.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.

source